Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Autoantibody against 14-3-3 zeta: a serological marker in detection of gastric cancer.

Qin J, Wang S, Wang P, Wang X, Ye H, Song C, Dai L, Wang K, Jiang B, Zhang J.

J Cancer Res Clin Oncol. 2019 Mar 18. doi: 10.1007/s00432-019-02884-5. [Epub ahead of print]

PMID:
30887154
2.
3.

The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment.

Li F, Li S, Wei L, Liang X, Zhang H, Liu J.

Biomarkers. 2013 Nov;18(7):632-7. doi: 10.3109/1354750X.2013.840800. Epub 2013 Sep 25.

PMID:
24066812
4.
5.

Role of blood tumor markers in predicting metastasis and local recurrence after curative resection of colon cancer.

Peng Y, Zhai Z, Li Z, Wang L, Gu J.

Int J Clin Exp Med. 2015 Jan 15;8(1):982-90. eCollection 2015.

6.

The significance of elevated plasma expression of microRNA 106b~25 clusters in gastric cancer.

Li F, Guo Y, Liu J, Zhang R.

PLoS One. 2017 May 31;12(5):e0178427. doi: 10.1371/journal.pone.0178427. eCollection 2017.

7.

Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population.

Chen XZ, Zhang WK, Yang K, Wang LL, Liu J, Wang L, Hu JK, Zhang B, Chen ZX, Chen JP, Zhou ZG, Mo XM.

Mol Biol Rep. 2012 Sep;39(9):9031-9. doi: 10.1007/s11033-012-1774-x. Epub 2012 Jun 30.

PMID:
22752725
8.

Using Serological Proteome Analysis to Identify Serum Anti-Nucleophosmin 1 Autoantibody as a Potential Biomarker in European-American and African-American Patients With Prostate Cancer.

Dai L, Li J, Xing M, Sanchez TW, Casiano CA, Zhang JY.

Prostate. 2016 Nov;76(15):1375-86. doi: 10.1002/pros.23217. Epub 2016 Jul 15.

PMID:
27418398
9.

Quantitative comparisons of summary receiver operating characteristics (sROC) curves among conventional serological tumor biomarkers for predicting gastric cancer in Chinese population.

Chen XZ, Zhang WH, Yang K, Zhang B, Chen ZX, Chen JP, Zhou ZG, Hu JK.

Tumour Biol. 2014 Sep;35(9):9015-22. doi: 10.1007/s13277-014-1986-x. Epub 2014 Jun 7.

PMID:
24906604
10.

Associations between serum CA724 and HER2 overexpression among stage II-III resectable gastric cancer patients: an observational study.

Chen XZ, Zhang WH, Chen HN, Liu JP, He D, Liu Y, Liu K, Chen XL, Mo XM, Zhou ZG, Hu JK.

Oncotarget. 2016 Apr 26;7(17):23647-57. doi: 10.18632/oncotarget.8145.

11.

Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.

Jing JX, Wang Y, Xu XQ, Sun T, Tian BG, Du LL, Zhao XW, Han CZ.

Asian Pac J Cancer Prev. 2014;15(23):10267-72.

12.

Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer.

Pan YQ, Ruan YY, Peng JB, Han QY, Zhang X, Lin A, Yan WH.

Hum Immunol. 2016 Apr;77(4):317-24. doi: 10.1016/j.humimm.2016.01.009. Epub 2016 Jan 11.

PMID:
26788811
13.

Levels of CEA, CA153, CA199, CA724 and AFP in nipple discharge of breast cancer patients.

Zhao S, Mei Y, Wang Y, Zhu J, Zheng G, Ma R.

Int J Clin Exp Med. 2015 Nov 15;8(11):20837-44. eCollection 2015.

14.

Multiple cytokine profiling in serum for early detection of gastric cancer.

Li J, Xu L, Run ZC, Feng W, Liu W, Zhang PJ, Li Z.

World J Gastroenterol. 2018 Jun 7;24(21):2269-2278. doi: 10.3748/wjg.v24.i21.2269.

15.

Tumor-associated autoantibody signature for the early detection of gastric cancer.

Zayakin P, Ancāns G, Siliņa K, Meistere I, Kalniņa Z, Andrejeva D, Endzeliņš E, Ivanova L, Pismennaja A, Ruskule A, Doniņa S, Wex T, Malfertheiner P, Leja M, Linē A.

Int J Cancer. 2013 Jan 1;132(1):137-47. doi: 10.1002/ijc.27667. Epub 2012 Jul 3.

16.

Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy.

Wang SY, Yeh CN, Lee HL, Liu YY, Chao TC, Hwang TL, Jan YY, Chen MF.

Ann Surg Oncol. 2009 Oct;16(10):2738-43. doi: 10.1245/s10434-009-0616-0. Epub 2009 Jul 28.

PMID:
19636636
17.

Circulating MicroRNA-21 Is a Potential Diagnostic Biomarker in Gastric Cancer.

Wu J, Li G, Wang Z, Yao Y, Chen R, Pu X, Wang J.

Dis Markers. 2015;2015:435656. doi: 10.1155/2015/435656. Epub 2015 May 3.

18.

Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.

Kunizaki M, Fukuda A, Wakata K, Tominaga T, Nonaka T, Miyazaki T, Matsumoto K, Sumida Y, Hidaka S, Yasutake T, Sawai T, Hamamoto R, Nanashima A, Nagayasu T.

Anticancer Res. 2017 Apr;37(4):1979-1984.

PMID:
28373470
19.

Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer.

Dai L, Li J, Tsay JJ, Yie TA, Munger JS, Pass H, Rom WN, Tan EM, Zhang JY.

Oncoimmunology. 2017 Mar 31;6(5):e1310359. doi: 10.1080/2162402X.2017.1310359. eCollection 2017.

20.

Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.

Wang YF, Feng FL, Zhao XH, Ye ZX, Zeng HP, Li Z, Jiang XQ, Peng ZH.

World J Gastroenterol. 2014 Apr 14;20(14):4085-92. doi: 10.3748/wjg.v20.i14.4085. Review.

Supplemental Content

Support Center